Complications of pazopanib in metastatic renal cell carcinoma (mRCC) in a single tertiary centre: a case series

被引：0
|
作者：
Alagappan, K. [1 ]
Nasuha, N. A. [1 ]
机构：
[1] Hosp Raja Perempuan Zainab II, Kota Bahru, Kelantan, Malaysia
来源：
BJU INTERNATIONAL | 2019年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
C-10033
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [1] Experience with first line pazopanib in patients with metastatic renal cell carcinoma in a single tertiary centre: A case series
    Kumarappan, A. L.
    Nasuha, N. A.
    BJU INTERNATIONAL, 2018, 122 : 12 - 12
  • [2] An indirect comparison analysis of pazopanib versus other agents in metastatic renal cell carcinoma (mRCC)
    McCann, L.
    Amit, O.
    Pandite, L.
    Amado, R. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] 10 year outcomes from a single-centre experience of sunitinib and pazopanib as first-line treatment of metastatic renal-cell carcinoma (mRCC).
    Chow, Shien
    Pillai, Manon Rhys
    Galvis, Victoria
    Leach, Rebecca
    Keene, Elizabeth
    Chan, Kevin
    Spencer-Shaw, Andrea
    Thistlethwaithe, Fiona
    Hawkins, Robert E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Single agent gemcitabine (gem) in metastatic renal cell carcinoma (mRCC).
    Hugec, V
    Koulova, L
    Garino, A
    Wiernik, PH
    Dutcher, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 452S - 452S
  • [5] An overview of pazopanib in metastatic renal cell carcinoma (mRCC) in Ministry of Health (MOH), Malaysia: A multicentre experience
    Malwinder, S.
    Nurazzahra, K.
    Sandya, S.
    Chen, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Pazopanib for the Treatment of Metastatic Renal Cell Carcinoma
    Pick, Amy M.
    Nystrom, Kelly K.
    CLINICAL THERAPEUTICS, 2012, 34 (03) : 511 - 520
  • [7] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Morales, Jose Manuel Ruiz
    Wells, J. Connor
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Beuselinck, Benoit
    Vaishampayan, Ulka N.
    Brugarolas, James
    Broom, Reuben James
    Bamias, Aristotelis
    Yuasa, Takeshi
    Srinivas, Sandhya
    Ernst, D. Scott
    Pezaro, Carmel Jo
    Wood, Lori
    Kollmannsberger, Christian K.
    Rini, Brian I.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [8] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the international metastatic renal cell carcinoma database consortium (IMDC).
    Morales, Jose Manuel Ruiz
    Swierkowski, Marcin
    Wells, Connor
    Fraccon, Anna Paola
    La Russa, Francesca
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Sim, Hao-Wen
    Beuselinck, Benoit
    Wood, Lori
    Yuasa, Takeshi
    Pezaro, Carmel Jo
    Rini, Brian I.
    Szczylik, Cezary
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Burden of cancer in metastatic renal cell carcinoma (mRCC).
    Battle, Dena
    Griffith, Meghan
    Msaouel, Pavlos
    Psutka, Sarah P.
    Vaishampayan, Ulka N.
    Zhang, Tian
    Staehler, Michael D.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [10] Case of pazopanib-induced thyrotoxicosis in a patient with metastatic renal cell carcinoma
    Sohei Kuribayashi
    Tetsuya Takao
    Yohei Okuda
    Masataka Kawamura
    Kosuke Nakano
    Nozomu Kishimoto
    Kentaro Takezawa
    Go Tanigawa
    Koichi Tsutahara
    Hirotaka Watanabe
    Yutaka Umayahara
    Seiji Yamaguchi
    International Cancer Conference Journal, 2017, 6 (3) : 118 - 120
12345